February 7, 2025

Could this startup’s compact nuclear reactors revolutionize cancer detection? – TechCrunch

Latest

AI

Amazon

Apps

Biotech & Health

Climate

Cloud Computing

Commerce

Crypto

Enterprise

EVs

Fintech

Fundraising

Gadgets

Gaming

Google

Government & Policy

Hardware

Instagram

Layoffs

Media & Entertainment

Meta

Microsoft

Privacy

Robotics

Security

Social

Space

Startups

TikTok

Transportation

Venture

Events

Startup Battlefield

StrictlyVC

Newsletters

Podcasts

Videos

Partner Content

TechCrunch Brand Studio

Crunchboard

Contact Us
As cancer rates in the West, and globally, tack upwards due to lifestyle and environmental pollution, so does the need for the nuclear isotopes used in detecting those cancers in a medical setting. But with many reactors built in the 70s and 80s scheduled for shutdown, the materials used are becoming rarer and more expensive. Now, a startup from Bristol, U.K. hopes to ramp up production of these materials by using a new, radical, technology. Astral Systems, co-founded by Talmon Firestone and Dr. Tom Wallace-Smith, employs something called multistate fusion (MSF) technology in its “compact reactors,” enabling the increased supply of the nuclear isotopes used in modern medicine. These reactors are in fact so compact that they can fit on the average desk.Astral has now closed over £4.5 million investment led by Austria-based VC Speedinvest and U.K.-based Playfair. The company says its approach will commercialize MSF technology, achieving better performance with greater efficiency and lower cost than traditional reactors.The approach employs so-called lattice confinement fusion (LCF), a concept first discovered by NASA. This can achieve solid-state fuel densities 400 million times higher than those achievable normally, according to the company.Leveraging earlier research from NASA, Astral also claims its platform could lead to other applications such as safe hybrid nuclear energy, space exploration, and industrial and security industry applications.Astral’s co-founder and CTO, Dr. Tom Wallace-Smith told TechCrunch: “The whole industry has been in sort of supply constraint historically because of this reliance on centralized reactors.”“Whereas what we’re proposing is placing them in industrial units or in the basement of hospitals or production centers. We can then produce the drugs exactly where they needed, and be able to reduce the reliance on these centralized production sites,” he added.He believes competitors are constrained by existing technology: “Most other approaches are based on linear, accelerated technology, whereas what we’re doing is essentially taking a very high TRL core architecture and putting in 2020 physics, where the ceiling is quite high in terms of performance. So we’re just at the start of what’s achievable with this,” he said.In a statement, Rick Hao, partner at Speedinvest added: “Astral Systems represents the best of UK deeptech. Astral is delivering a fresh approach to nuclear fusion that addresses urgent medical, industrial and power needs.”So far Astral has established three commercial fusion facilities from which it’s already generating revenues.Also participating in the round was participation of angel investors including Oliver Buck, founder of ITM Isotope Technologies, and former ARM president of Product Group, Pete Hutton. Topics
Editor At Large
Mike Butcher (M.B.E.) is Editor-at-large of TechCrunch. He has written for UK national newspapers and magazines and been named one of the most influential people in European technology by Wired UK. He has spoken at the World Economic Forum, Web Summit, and DLD. He has interviewed Tony Blair, Dmitry Medvedev, Kevin Spacey, Lily Cole, Pavel Durov, Jimmy Wales, and many other tech leaders and celebrities. Mike is a regular broadcaster, appearing on BBC News, Sky News, CNBC, Channel 4, Al Jazeera and Bloomberg. He has also advised UK Prime Ministers and the Mayor of London on tech startup policy, as well as being a judge on The Apprentice UK. GQ magazine named him one of the 100 Most Connected Men in the UK. He is the co-founder of TheEuropas.com (Top 100 listing of European startups); and the non-profits Techfugees.com, TechVets.co, and Startup Coalition. He was awarded an MBE in the Queen’s Birthday Honours list in 2016 for services to the UK technology industry and journalism. Government agency removes spoon emoji from work platform amid protests
DOGE staffer steps down after racist posts emerge
GitHub Copilot brings mockups to life by generating code from images
Researchers created an open rival to OpenAI’s o1 ‘reasoning’ model for under $50
Bench burned through $135 million before shutting down
The biggest breach of US government data is under way
Workday cuts nearly 2,000 employees
Subscribe for the industry’s biggest tech newsEvery weekday and Sunday, you can get the best of TechCrunch’s coverage.TechCrunch’s AI experts cover the latest news in the fast-moving field.Every Monday, gets you up to speed on the latest advances in aerospace.Startups are the core of TechCrunch, so get our best coverage delivered weekly.By submitting your email, you agree to our Terms and Privacy Notice.© 2024 Yahoo.

Source: https://techcrunch.com/2025/02/06/could-this-startups-compact-nuclear-reactors-revolutionize-cancer-detection/

Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright © All rights reserved. | Newsphere by AF themes.